MICHELLE HOPKINS: Open Payments
NPI 1487015939 · ANKENY, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 34 payments from 8 companies in 2025. Trend: 2023 $469 · 2024 $750 · 2025 $599
Food & beverage: $415Education: $184
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $273 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $216 |
| Organon LLC | 3 | $27 |
| Amgen Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $15 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: TREMFYA, ILUMYA, VTAMA, OTEZLA, SOFDRA, NEMLUVIO, Zoryve, COSENTYX.
Industry payments across IA — which companies pay providers there.
